Referral patterns for oral squamous cell carcinoma in Australia: 20 years progress

Kaing, Lee; Manchella, Sankar; Love, C.C.; Nastri, A.; Wiesenfeld, D.

doi:10.1111/adj.12314

Cited by 26 publications

(45 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The diagnostic interval also showed a wide range of values . The longest intervals were published in the 1980s in the USA, and more recently in Australia and Iran . The shortest diagnostic periods—21 and 22 days—were reported from European countries .…”

Section: Resultsmentioning

confidence: 92%

“…A total of 1089 potentially eligible articles were identified, and 22 of them finally met the inclusion criteria ( κ =0.73; IC95%=0.56‐0.89; Figure ). The summarised information comes from 2710 patients with oral cancer or oropharyngeal cancer, mainly retrieved in Europe, from 1970 to 2010, although there are also reports on investigations conducted in USA, India, Australia, Japan, Argentina and Iran (Table ) …”

Section: Resultsmentioning

confidence: 99%

“…These papers also discuss potential biases associated to the measurements of time points, but only two of them have mentioned the need for a theoretical validation and reference the theoretical framework . The reports eliciting a modest quality score (≤7) were mainly published before 1995, and all of them include clearly defined begin and end points for their investigations …”

Section: Resultsmentioning

confidence: 99%

“…No paper has provided data about every interval considered in this review, as only four papers have considered the total interval between the detection of a bodily change until the start of treatment. These papers report on 527 patients and revealed an average duration of 186.7 days for this period.…”

Section: Resultsmentioning

confidence: 99%

“…These papers report on 527 patients and revealed an average duration of 186.7 days for this period. On the contrary, a number of studies offered information about the patient interval with a weighted mean, calculated from 2151 patients, of 80.3 days. The range of elicited values was wide, although the shortest published intervals were reported from Europe (the Netherlands with 28 days‐ and Finland with 30‐42 days).…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

The length of patient and primary care time interval in the pathways to treatment in symptomatic oral cancer. A quantitative systematic review

Varela‐Centelles

Seoane

López-Cedrún

et al. 2017

Clinical Otolaryngology

View full text Add to dashboard Cite

Objectives: To examine the relative length of the patient and primary care intervals in symptomatic oral cancer.Design: Quantitative systematic review. Search strategy: Oral cancer OR oral squamous cell carcinoma OR oropharyngeal cancer AND time interval OR diagnostic delay.Setting: Primary and secondary care.Participants: Oral and oropharyngeal cancer patients. Main outcome measures:We computed five measures (patient, primary care, diagnosis, total diagnosis and total treatment intervals). Most studies did not provide any dispersion measure. We then used the sample size of each study to compute a weighted average of the mean intervals. When the median was provided, we assumed normality of the distribution of the means and used the median as a proxy of the mean.Results: A total of 1089 articles were identified, and 22 met the inclusion criteria, reporting on 2710 patients from Europe, USA, India, Australia, Japan, Argentina and Iran. The weighted average of patient interval was 80.3 days. Primary care interval was five times shorter: 15.8 days. The diagnostic interval was appreciably shorter (47.9 days) when compared with the patient interval during symptomatic period.Conclusions: Patient interval represents the major component of waiting times since the detection of the first signs/symptoms to the definitive diagnosis of oral cancer. Thus, strategies focused on high-risk patients should be prioritised. Interventions aimed at optimising the health systems should be implemented by monitoring and facilitating diagnostic and treatment pathways of patients with oral cancer.

show abstract

Section: Resultsmentioning

confidence: 92%

Section: Resultsmentioning

confidence: 99%